Connection

Paolo Maggi to Heterocyclic Compounds, 3-Ring

Back to Details
This is a "connection" page, showing publications Paolo Maggi has written about Heterocyclic Compounds, 3-Ring.
Paolo Maggi
Connection Strength
0.170
Heterocyclic Compounds, 3-Ring
  1. Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. AIDS. 2017 01 28; 31(3):455-457.
    View in: PubMed
    Score: 0.133
  2. Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). BMC Infect Dis. 2018 07 31; 18(1):357.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.